NCT05082428View on ClinicalTrials.gov

This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

May 30, 2022

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions
Ulcerative Colitis
Trial Locations (1)

Unknown

Pfizer, Helsinki

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY